Events

6th Annual Immuno-Oncology 360

February 26-28, 2020 – Crowne Plaza Times Square, New York City, NY
New Scientific Frontiers in Cell Therapies for Solid Tumors

CAR-TCR Europe

February 24-27, 2020 – Hotel Novotel London West, London, UK
Translational Strategies to Prevent Toxicity

Antibody Engineering & Therapeutics

December 9-13, 2019 – Marriott Marquis San Diego, San Diego, CA
TCR-mimic Antibodies against Intracellular Target for Cancer Immunotherapy: Targeting Alpha-fetoprotein (AFP) in Advanced Hepatocellular Carcinoma

61st American Society of Hematology (ASH) Annual Meeting

December 7-10, 2019 – Orange County Convention Center (OCCC), Orlando, FL
Poster Presentation – First-in-Human Study of ET019003, a Next Generation Anti-CD19 T-Cell Therapy, in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL)

EPPICon 2019

September 28, 2019 – Santa Clara Convention Center, Santa Clara, CA
Panel Discussion – The Promise of Cell Therapy

CAR-TCR Summit 2019

September 10-13, 2019 – Seaport Hotel & WTC, Boston, MA
ET140202 T-Cell Therapy in Advanced Liver Cancer (Hepatocellular Carcinoma)
A Novel Antibody-T cell Receptor (AbTCR) ARTEMIS” T-cell Platform Designed to Prevent T-Cell Hyperactivation

CAR-TCR Summit Asia 2019

June 18-20, 2019 – Shanghai, China
Antibody-TCR ARTEMIS” T-cell Therapy for Solid Tumors & Hematological Malignancies

Alexa Willson

CFO

Alexa Willson has served as the Chief Financial Officer of Eureka Therapeutics since August 2022. Prior to joining the company, She was a Managing Partner of Cloudstone Venture Capital, an early-stage healthtech venture firm since October 2020. Cloudstone is also an investor of Eureka Therapeutics.

Ms. Willson has over 25 years of experience advising public and private companies on corporate finance, strategy, capital raising, valuation, mergers & acquisitions, and other matters. She has founded and run a midmarket investment banking boutique and worked with large Wall Street investment banks, including Kidder Peabody and Drexel Burnham.

Ms. Willson has served on private and non-profit boards and investment committees in various capacities. She teaches financial literacy. Ms. Willson holds a BA from Harvard and an MBA from Stanford Graduate School of Business.